Sat 24 Oct 2026 International edition

Healthcare News & Policy Cannabis use linked to 37% higher stroke risk in massive study

Public Health & Epidemiology Digital Canvas, Cognitive Renewal: How AI-Assisted Art Therapy is Transforming Elder Care for Mild Cognitive Impairment

Toxicology & Pharmacology Decoding the Microbiome: Landmark Princeton Studies Reveal How Plant Diets and Indigestible Proteins Shape Human Health

Laboratory Medicine Illuminating the Dark: Double Chooz Collaboration Measures Post-Shutdown Antineutrino Emissions from Nuclear Reactors

Pathology & Histology Breakthrough in Computational Pathology: Introducing PRISM2, the First Clinical-Grade Multimodal Slide-Level Foundation Model

Biochemistry & Metabolomics Beyond Man’s Best Friend: How Co-Evolution, Climate, and Culture Forged the 15,000-Year Bond Between Humans and Dogs

Healthcare News & Policy Beyond Shingles: Landmark Study Reveals Newest Vaccine May Significantly Lower Dementia Risk in Vulnerable Older Adults

Medical Devices & Lab Automation Pioneering Precision: How UMass Amherst Researchers Are Reworking Ablation Technology to Revolutionize Bladder Cancer Treatment

Medical Biotechnology Tracing the Tuber: How Ancient Andean Potato Farming Rewrote the Human Genome

Oncology & Cancer Research Unlocking Nature’s Oncology Secrets: How a Colorful Pet Gecko is Revolutionizing Cancer Research

Hematology & Blood Research Executive Overview: The Hidden Toll of Leukaemia Caregiving

Biochemistry & Metabolomics Silent Threat in the Fields: Landmark Virginia Tech Study Reveals How Glyphosate Subtly Undermines Honeybee Colonies

Archive

Tag: bispecific

AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology

Clinical Trials & Research

AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology

Executive Overview The landscape of immuno-oncology has long been defined by the pursuit of combination therapies and multi-targeted biologic agents...

23 Aug 2026